Trouble with the latest dance move? GABA chemical messenger might be to blame

March 3, 2011

If you tend to have trouble picking up the latest dance moves or learning to play a new piano piece, there might be an explanation. A new study published online on March 3rd in Current Biology, a Cell Press publication, shows that people who are fast to learn a simple sequence of finger motions are also those whose brains show large changes in a particular chemical messenger following electrical stimulation.

That , known as , is important for the plasticity of the , a brain region involved in planning, control, and execution of voluntary movements.

"There is considerable variability in motor learning behavior across individuals," said Charlotte Stagg of the University of Oxford. "We aimed to test whether some of this variability could be explained by variation in responsiveness of the GABA system."

The researchers used to directly measure GABA levels in the brain both before and after a low-level current was delivered through research participants' scalps. That procedure, called anodal transcranial direct current stimulation (tDCS), is known to produce a decrease in GABA within the motor cortex. The exercise therefore allowed the researchers to quantify individuals' baseline GABA levels and their "GABA responsiveness."

On a separate day, those individuals were asked to learn a sequence of finger motions while their brains were again scanned by (fMRI). It turned out that those who were more GABA responsive were also quicker to learn the simple motor task. The brains of more GABA-responsive individuals also showed greater activation in the motor cortex during learning. The researchers also found that those with higher GABA concentrations at baseline tended to have slower reaction times and less during learning.

The findings suggest that GABA responsiveness may be key in the motor cortex for making the that are the cellular basis for learning and memory, the researchers say. They also offer an important window into recovery after brain injury, such as a stroke.

GABA levels can change after that kind of brain trauma, and the findings support the idea that treatments designed to influence GABA levels might improve learning. In fact, tDCS is already in use as a tool for motor rehabilitation in stroke patients.

"This shows how that might work," Stagg said. It may also lead to strategies for making those improvements longer lasting, she added.

Related Stories

Recommended for you

Study finds walnuts may promote health by changing gut bacteria

July 28, 2017
Research led by Lauri Byerley, PhD, RD, Research Associate Professor of Physiology at LSU Health New Orleans School of Medicine, has found that walnuts in the diet change the makeup of bacteria in the gut, which suggests ...

Green tea ingredient may ameliorate memory impairment, brain insulin resistance, and obesity

July 28, 2017
A study published online in The FASEB Journal, involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose ...

Manipulating a type of brain cell gets weight loss results in mice

July 28, 2017
A new study has found something remarkable: the activation of a particular type of immune cell in the brain can, on its own, lead to obesity in mice. This striking result provides the strongest demonstration yet that brain ...

Team finds link between backup immune defense, mutation seen in Crohn's disease

July 27, 2017
Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients, though the link between biological housekeeping and inflammatory bowel disease remained a mystery. Now, researchers ...

Study finds harmful protein on acid triggers a life-threatening disease

July 27, 2017
Using an array of modern biochemical and structural biology techniques, researchers from Boston University School of Medicine (BUSM) have begun to unravel the mystery of how acidity influences a small protein called serum ...

CRISPR sheds light on rare pediatric bone marrow failure syndrome

July 27, 2017
Using the gene editing technology CRISPR, scientists have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.